The next meeting of the Transparency Council will be held on Monday, October 3.
AOTMiT: Transparency Council incl. on the prevention of pneumococcal infections
Published Sept. 27, 2022 08:43
Źródło: AOTMiT
The agenda includes:
Preparation of an opinion on the legitimacy of introducing changes to the draft drug program B.101. "Treatment with pcsk-9 inhibitors or inclisiran in patients with lipid disorders (ICD-10 E78.01, I21, I22, I25)".
Preparation of positions on the legitimacy of granting consent for the reimbursement of the Raxone (idebenone) medicinal product in the following indications:
Leber's hereditary optic neuropathy;
Leber's hereditary optic neuropathy - continued treatment where the patient benefited.
Preparation of opinions on draft health policy programs of local government units:
"Kajtek - co-financing program for the treatment of infertility by in vitro fertilization for the inhabitants of the City of Suwałki in the years 2023-2025",
"Program for the prevention of pneumococcal infections among residents of Biała Podlaska aged 60+".
Source: AOTMiT
